Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, Insmed Inc (NASDAQ: INSM) closed at $132.6 up 2.43% from its previous closing price of $129.45. In other words, the price has increased by $2.43 from its previous closing price. On the day, 2.24 million shares were traded. INSM stock price reached its highest trading level at $132.64 during the session, while it also had its lowest trading level at $128.5.
Ratios:
For a deeper understanding of Insmed Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.33 and its Current Ratio is at 6.68. In the meantime, Its Debt-to-Equity ratio is 0.59 whereas as Long-Term Debt/Eq ratio is at 0.59.
On August 13, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight but kept the price unchanged to $126.
On May 13, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $105.Jefferies initiated its Buy rating on May 13, 2025, with a $105 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 20 ’25 when SHAROKY MELVIN MD sold 10,000 shares for $129.50 per share. The transaction valued at 1,295,000 led to the insider holds 274,516 shares of the business.
Adsett Roger sold 25,000 shares of INSM for $3,189,586 on Aug 19 ’25. The Chief Operating Officer now owns 105,637 shares after completing the transaction at $127.58 per share. On Aug 18 ’25, another insider, Lewis William, who serves as the Chair and CEO of the company, sold 6,865 shares for $128.40 each. As a result, the insider received 881,470 and left with 233,924 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSM now has a Market Capitalization of 28028327936 and an Enterprise Value of 26910574592. For the stock, the TTM Price-to-Sale (P/S) ratio is 70.40 while its Price-to-Book (P/B) ratio in mrq is 22.40. Its current Enterprise Value per Revenue stands at 67.597 whereas that against EBITDA is -29.332.
Stock Price History:
The Beta on a monthly basis for INSM is 0.95, which has changed by 0.6818874 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, INSM has reached a high of $130.13, while it has fallen to a 52-week low of $60.40. The 50-Day Moving Average of the stock is 24.23%, while the 200-Day Moving Average is calculated to be 62.73%.
Shares Statistics:
For the past three months, INSM has traded an average of 3.89M shares per day and 3647990 over the past ten days. A total of 211.11M shares are outstanding, with a floating share count of 206.66M. Insiders hold about 2.23% of the company’s shares, while institutions hold 99.06% stake in the company. Shares short for INSM as of 1753920000 were 9537045 with a Short Ratio of 2.45, compared to 1751241600 on 9796337. Therefore, it implies a Short% of Shares Outstanding of 9537045 and a Short% of Float of 5.0.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Current recommendations for the stock of the company come from 13.0 analysts. The consensus estimate for the next quarter is -$1.19, with high estimates of -$0.93 and low estimates of -$1.94.
Analysts are recommending an EPS of between -$5.07 and -$6.08 for the fiscal current year, implying an average EPS of -$5.51. EPS for the following year is -$4.02, with 13.0 analysts recommending between -$2.37 and -$9.14.
Revenue Estimates
A total of 16 analysts believe the company’s revenue will be $113.94M this quarter.It ranges from a high estimate of $121.97M to a low estimate of $106M. As of the current estimate, Insmed Inc’s year-ago sales were $93.42MFor the next quarter, 16 analysts are estimating revenue of $153.85M. There is a high estimate of $176.11M for the next quarter, whereas the lowest estimate is $132M.
A total of 18 analysts have provided revenue estimates for INSM’s current fiscal year. The highest revenue estimate was $498.14M, while the lowest revenue estimate was $446M, resulting in an average revenue estimate of $469.11M. In the same quarter a year ago, actual revenue was $363.71MBased on 16 analysts’ estimates, the company’s revenue will be $1.05B in the next fiscal year. The high estimate is $1.41B and the low estimate is $865M.
